Prediction of thyroid hormone supplementation after thyroid lobectomy

Area of Science:

• Endocrinology
• Thyroid Surgery
• Neurosurgery

Background:

• Thyroid function post-thyroid lobectomy is crucial for patient management.
• Assessing thyroid-stimulating hormone (TSH) levels helps monitor thyroid health.
• Identifying predictors of hypothyroidism is key for effective treatment strategies.

Purpose of the Study:

• To evaluate thyroid function after thyroid lobectomy.
• To determine if preoperative measurements predict postoperative hypothyroidism.
• To identify patients needing levothyroxine treatment post-surgery.

Main Methods:

• Retrospective analysis of 276 thyroid lobectomy patients (2003-2012).
• Examined correlations between preoperative factors (age, sex, thyroid volume, thyroiditis, free T4, TSH, microsomal antibodies) and postoperative levothyroxine use.
• Statistical analysis to identify significant predictors.

Main Results:

• 23.6% of patients required postoperative levothyroxine.
• Preoperative TSH strongly correlated with 1-month postoperative TSH (P < 0.001).
• Preoperative TSH >2.5 mIU/L and positive microsomal antibodies significantly predicted levothyroxine need (RR 8.933 and 3.438, respectively).
• High-risk group (TSH >2.5 mIU/L, positive antibodies) had 77.8% levothyroxine requirement vs. 7% in low-risk group (TSH <2.5 mIU/L, negative antibodies).

Conclusions:

• Preoperative TSH levels and microsomal antibody status are significant predictors of levothyroxine supplementation post-thyroid lobectomy.
• Patients with preoperative TSH <2.5 mIU/L demonstrate a low risk for requiring postoperative levothyroxine.